Ocugen, Inc.
Long

OCGN Ocugen new Covid-19 Vaccine and Price Target

934
OCGN Ocugen partnered with Bharat Biotech for Covaxin, the first COVID vaccine developed in India to receive emergency authorization.

With the COVID significant rise in cases, hospitalizations and deaths over the last two weeks, vaccines producers are rising once again.

My short term Price Target is 10.30usd

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.